What end of Eli Lilly's weight-loss drug shortage means for the competition [Yahoo! Finance Canada]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance Canada
Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand. The metrics used to determine the current demand is not specified by the FDA — and the drug shortages page provides an important caveat: "Even when a medication is available, patients may not always be able to immediately fill their prescription at a particular pharmacy," the FDA said on its site addressing the Mounjaro and Zepbound listing. Eli Lilly first notified the agency in August that its drugs were no longer in shortage, resulting in the initial removal of both drugs from the agency's drug shortage list . The FDA then verified through its own assessment, which prompted the notification Thursday. The move is important for two key reasons: It gives Lilly an edge over competitor Novo Nordisk ( NVO ), which still has doses in shortage, and it starts a countdown clock for compounding pharmacies to cease production of copycats of Lilly's drugs, known by their fo
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list [Yahoo! Finance Canada]Yahoo! Finance Canada
- What end of Eli Lilly's weight-loss drug shortage means for the competition [Yahoo! Finance]Yahoo! Finance
- England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access [Yahoo! Finance]Yahoo! Finance
- NHS proposes phased launch for Eli Lilly's Mounjaro [Yahoo! Finance]Yahoo! Finance
- Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound [USA TODAY]USA TODAY
LLY
Earnings
- 8/8/24 - Beat
LLY
Sec Filings
- 9/18/24 - Form 3
- 9/17/24 - Form 4
- 9/17/24 - Form 4
- LLY's page on the SEC website